ArticleMolecular therapy oncolytics2019

ROS/KRAS/AMPK Signaling Contributes to Gemcitabine-Induced Stem-like Cell Properties in Pancreatic Cancer.

Hengqiang Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.